ChatGPTを活用して業務のAI化を進めています。プロンプトエンジニアリングの専門家です！と、名乗れるレベルではありませんが、かなり色々使いこなしてきています。この１年、病気で失われた能力は、別な能力を発達させる、進化することで生き残っていこうと思います。
<><><>
<>
24/05/31
The Rationale, Evidence, and Adaptations to Pulmonary Rehabilitation for Chronic Respiratory Diseases Other Than COPD
RA Evans - Respiratory Care, 2024
… This article uses the examples of interstitial lung disease including idiopathic pulmonaryfibrosis, bronchiectasis, pulmonary hypertension, post lung transplantation, and post-COVID condition to highlight exemplar clinical problems. In …
[PDF] FIBROTIC LUNG DISEASE
I Belo - 2024
… Idiopathic pulmonary fibrosis (IPF) has gained a lot of attention by the research community in recent decades. Thanks to enhanced understanding on pathophysiological mechanisms behind the fibrosing process together with two …
- 線維性肺疾患
Development of an integrated data mining toolkit for the investigation of fibromics data
D Fanidis - 2024
… Among this long list of diseases lies idiopathic pulmonary fibrosis, the most lethal of the idiopathic interstitial pneumonias. Until now there … In this thesis, in silico methods have been utilized in order to propose novel disease biomarkers and …
- 線維化データの調査のための統合データマイニングツールキットの開発
Unveiling the Molecular Hallmarks of Peyronie's Disease: A Comprehensive Narrative Review-Beyond the Abstract
A Şahin, M Gül
… While fibrotic diseases can manifest systemically (such as systemic sclerosis), they typically exhibit tissue-specific patterns (as seen in idiopathic pulmonary fibrosis). Among urogenital fibrotic disorders in males, Peyronie's disease is one of the most …
- ペロニー病の分子特性の解明：包括的な物語レビュー - 抽象を超えて
Pirfenidone treatment reduces cardiac allograft vasculopathy in a mouse model
C Graebner, M Scheunchen, F Theil, A Kuckhahn… - Cardiovascular Research, 2024
… Pirfenidone is an anti-fibrotic drug with anti-inflammatory properties that is already approved for treatment of idiopathic pulmonary fibrosis. …
- ピルフェニドン治療はマウスモデルにおける心臓移植血管症を軽減する
Obesity and Lung Disease: A Guide to Pathophysiology, Evaluation, and Management
AE Dixon
… BMI is associated with better survival in patients with idiopathic pulmonary fibrosis[95–97]. … Does body mass index influence survival of patients with idiopathic pulmonaryfibrosis? Eur … Body mass index and mortality in patients with idiopathic …
- 肥満と肺疾患：病態生理学、評価、管理のガイド
24/05/30
[PDF] EPITHELIAL CELLS IN PULMONARY FIBROSIS
K Kosunen - 2024
… Idiopathic pulmonary fibrosis (IPF) is a form of this condition where the precise etiology is unknown. IPF is an aggressively progressive disease … IPF is a molecularly complex disease. Central to the pulmonary fibrotic response in the lung …
- 肺線維症における上皮細胞
[PDF] Bilateral Coronary Artery Fistulas and Pulmonary Sequestration. An Unusual Combination of a Rare Disease: Case Report and Review of the Literature
A Mortele, M Belmonte, E Bogaerts, M Vanderheyden - J, Clinical Case Reports and …, 2024
… In this case report an 83-year-old male with newly diagnosed idiopathic pulmonaryfibrosis, history of ischemic cardiomyopathy and severe tricuspid regurgitation was admitted for syncope. Due to episodes of non-sustained …
- 両側冠動脈瘻と肺分画症。稀な疾患の珍しい組み合わせ：症例報告と文献レビュー
[HTML] Influence of intersignaling crosstalk on the intracellular localization of YAP/TAZ in lung cells
IA Govorova, SY Nikitochkina, EA Vorotelyak - Cell Communication and Signaling, 2024
… The lung fibroblasts of patients with idiopathic pulmonary fibrosis showed high nuclear … in AT2 and bronchiolar epithelial cells of idiopathic pulmonary fibrosis patient lungs [72]. Moreover, a … new therapeutic approaches for the treatment of …
- 肺細胞におけるYAP/TAZの細胞内局在に対するシグナル伝達クロストークの影響
24/05/28
Detection of Idiopathic Pulmonary Fibrosis Lesion Area Based on Transfer Learning
JL Xue, T Pu, L Guo, ZM Peng, X He, Y Han - 2024 16th International Conference on …, 2024
… Given the difficulty in obtaining annotated IPFdata, we propose to construct natural texture datasets similar to IPF lesion areas to improve … In this paper, we extract images with similar IPFtexture characteristics from the two datasets and …
- 転移学習に基づく特発性肺線維症病変領域の検出
24/05/27
[HTML] Body mass index is associated with clinical outcomes in idiopathic pulmonary fibrosis
HY Yoon, H Kim, Y Bae, JW Song - Scientific Reports, 2024
… prognosis in patients with idiopathicpulmonary fibrosis (IPF) remains uncertain. We investigated the association between BMI and clinical outcomes in patients with IPF using national health claims data. The study included 11,826 patients with IPF …
[HTML] Understanding the lived experience of idiopathic pulmonary fibrosis and how this shapes views on home-based pulmonary rehabilitation in Delhi, India
H Hanif, O Ahmed, J Manifield, R Ishrat, I Pina… - Chronic Respiratory …, 2024
… Pulmonary Rehabilitation (PR) is a high-impact intervention for individuals with idiopathicpulmonary fibrosis (IPF) but access is limited in … disproportionate to the immense burden of IPF in India. We explored the lived experiences of people living …
- 特発性肺線維症の実体験を理解し、それがインドのデリーにおける在宅肺リハビリテーションに対する見方にどのように影響するか
Impact of Pirfenidone on arrhythmic and clinical outcomes in patients with idiopathic pulmonary fibrosis
SI Im - Europace, 2024
… of patients diagnosed with IPF from 2008 to 2023 was used to obtain echocardiography, electrocardiogram, and 24hr-holter monitoring data. Inclusion criteria were all IPF patients with/… And obesity was associated with higher …
[PDF] End-Stage Idiopathic Pulmonary Fibrosis (IPF) Presumably Associated with Biomass Smoke Exposure: A Case Report from Kenya
VC Onyango
… Idiopathic pulmonary fibrosis (IPF) is the most common form of interstitial lung disease and is classified as idiopathic interstitial pneumonia … IPF is characterized by a spontaneously occurring chronic fibrosing interstitial pneumonia that is limited …
[PDF] The Role of Myocardin And Its Effector Proteins In TGF-β Induced Cytoskeletal Remodeling of IPF Fibroblasts
KA OLAWUYI - 2024
… Idiopathic pulmonary fibrosis (IPF) is characterized by thickening and stiffness around the air sacs. Approved treatments like nintedanib … Idiopathic pulmonary fibrosis Idiopathicpulmonary fibrosis (IPF) is a chronic interstitial lung disease that …
24/05/26
[HTML] Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes
Z Liu, Z Peng, H Lin, K Zhou, L Liang, J Cao, Z Huang… - Respiratory Research, 2024
… Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic interstitial lung disease characterized by progressive dyspnea … It is of great significance to discover new drug targets for IPF. … Idiopathic pulmonary fibrosis (IPF) is a chronic progressive …
- 特発性肺線維症の潜在的薬剤標的の特定：薬剤候補遺伝子に基づくメンデルランダム化研究
[HTML] Experiences of living with idiopathic pulmonary fibrosis in relation to physical activity-“How the hills became steeper and steeper”: a qualitative interview study
A Jernås, M Fagevik Olsén, E Holmqvist… - BMC Pulmonary Medicine, 2024
… Idiopathic pulmonary fibrosis (IPF) is a progressive disease presenting with symptoms like dyspnoea, dry cough, and fatigue, which affect physical function and quality of life. No earlier qualitative studies have investigated physical activity in IPF …
- 特発性肺線維症患者の生活と身体活動の関係 - 「丘がどんどん急になった理由」：質的インタビュー調査
CSF3 aggravates acute exacerbation of pulmonary fibrosis by disrupting alveolar epithelial barrier integrity
B Guo, W Liu, X Ji, B Xi, X Meng, W Xie, Y Sun… - International …, 2024
… Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive respiratory disorder characterized by poor prognosis, often presenting with … types of ILD, idiopathicpulmonary fibrosis (IPF) is the most common and the largest lethal group …
- CSF3は肺胞上皮バリアの完全性を破壊することで肺線維症の急性増悪を悪化させる
The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
M Ghanem, G Archer, B Crestani, AA Mailleux - Pharmacology & Therapeutics, 2024
… Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease for which therapeutic options are limited, with an unmet need to … So far, the effect of FGF19 during pulmonary fibrosis was poorly described. Recently, our team reported that …
- 内分泌 FGF 軸: 肺線維形成を予防できる全身性抗線維化反応?
[PDF] From Pixels to Prognosis: Unlocking the Potential of Deep Learning in Fibrotic Lung Disease Imaging Analysis
SDLO Kett Morais, FN Felder, SLF Walsh - British Journal of Radiology, 2024
… The licensing of antifibrotic therapy for fibrotic lung diseases, including idiopathic pulmonaryfibrosis IPF has created an urgent need for reliable biomarkers to predict disease progression and treatment response. Some patients experience stable …
[PDF] The role of interleukin‐36 in health and disease states
K Sugiura, H Fujita, M Komine, K Yamanaka… - Journal of the European …, 2024
… Levels of IL- 36α/γ are significantly higher in patients with IPF than healthy controls,104,105 with higher levels associated with poorer lung … Serum IL- 36 cytokines levels in idiopathicpulmonary fibrosis and connective tissue disease …
- 健康状態と病状におけるインターロイキン36の役割
<>
<><><>
特発性肺線維症( idiopathic pulmonary fibrosis (IPF) )関連の学術的情報収集してシェアしています。Google Scholar SearchのUpdateを定期的に掲載しています。GoogleのAIが一定の重み付けはしているとは思いますが、玉石混交です。
当面、毎週アラートの内容をアップしていこうと思います。
###
